How many stem-cell trials for Multiple Sclerosis are recruiting right now?
13 of 92 registered studies were open to enrolment in the 2026-08-29 snapshot — 14% of everything ever registered for this condition with a stem-cell intervention.
Who these studies will actually take
AHSCT protocols require relapsing-remitting disease with recent inflammatory activity, a disability ceiling and transplant fitness. Progressive disease without activity is usually excluded — which is exactly the group most often sold commercial infusions abroad.
The studies currently enrolling
| Study | Phase | Status | Planned n | Lead sponsor | Start |
|---|---|---|---|---|---|
| NCT02795052 — Neurologic Stem Cell Treatment Study | n/a | Recruiting | 500 | MD Stem Cells | 2016-06 |
| NCT05832515 — AHSCT With Fludarabine and Cyclophosphamide Based Conditioning Regimes in Patients With Multiple Sclerosis | Phase 1 | Recruiting | 200 | St. Petersburg State Pavlov Medical University | 2020-10-01 |
| NCT04121468 — A Phase I Double Blind Study of Metformin Acting on Endogenous Neural Progenitor Cells in Children and Young Adults With Multiple Sclerosis | Phase 1, Phase 2 | Recruiting | 20 | The Hospital for Sick Children | 2020-02-24 |
| NCT06267781 — RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line Therapies | n/a | Recruiting | 30 | IRCCS San Raffaele | 2022-09-02 |
| NCT07635693 — ATLG Levels in Autologous HSCT for Multiple Sclerosis | n/a | Recruiting | 20 | Ciceri Fabio | 2026-05-04 |
| NCT06065852 — National Registry of Rare Kidney Diseases | n/a | Recruiting | 35,000 | UK Kidney Association | 2009-11-06 |
| NCT05532943 — Evaluate the Safety and Efficacy of Allogeneic Umbilical Cord Mesenchymal Stem Cells in Patients With Multiple Sclerosis | Phase 1, Phase 2 | Recruiting | 41 | Ever Supreme Bio Technology Co., Ltd. | 2023-09-08 |
| NCT06567197 — Multiple Sclerosis Treatment With Autologous Hematopoietic Stem Cell Transplantation in the Netherlands | n/a | Recruiting | 24 | Amsterdam UMC, location VUmc | 2023-08-25 |
What recruiting does and does not mean
Recruiting means a sponsor has an approved protocol and is looking for participants who meet specific criteria. It does not mean the therapy is on sale, that you qualify, or that earlier studies were positive. Records are also left as recruiting after enrolment stalls, so the contact block on the registry page matters more than the label.
Sites sit in 31 countries, led by United States. Travelling for a trial rarely works unless the site has confirmed in writing that it can enrol non-residents and fund the follow-up schedule.
Who is running the studies here
Lead sponsors appearing most often for this condition. Useful for one specific check: whether the entity quoting research at you appears anywhere in it.
- Fred Hutchinson Cancer Center — 3 registered records
- Talaris Therapeutics Inc. — 3 registered records
- Tisch Multiple Sclerosis Research Center of New York — 3 registered records
- Northwestern University — 3 registered records
- St. Petersburg State Pavlov Medical University — 2 registered records
- Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud — 2 registered records
Frequently asked
How many stem-cell trials for Multiple Sclerosis are recruiting right now?
13 of 92 registered records (2026-08-29).
Can I join one of these trials?
Possibly, if the criteria fit and a site can take you. Nobody can promise a place on your behalf, and any intermediary charging a fee to arrange one is not part of the trial.
Do trials charge participants?
Participants are not usually billed for the study product. A five-figure invoice attached to a supposed trial place means you are buying a treatment, not joining research.
Registry and literature counts retrieved 2026-08-29 (ClinicalTrials.gov API v2; PubMed E-utilities). Registration or publication volume measures research activity, not effectiveness or approval. Educational information — not medical advice; verify product, indication, legal pathway and evidence with an independent qualified physician. Page generated 2026-08-29. See our editorial standards.
More on this condition
- Multiple Sclerosis: cell-therapy evidence and registered trials
- How much does stem cell therapy for Multiple Sclerosis cost? (2026)
- Multiple Sclerosis stem cell therapy — your questions answered (2026)
- Multiple Sclerosis: cell-therapy evidence by therapy class
- MSC vs HSCT for Multiple Sclerosis: what the registries show